The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent

Pediatric Diabetes

Volumn 13, Issue 6, 2012, Pages

  Gozlan, Yael ^a,c   Tenenbaum, Ariel ^a   Shalitin, Shlomit ^a,c   Lebenthal, Yael ^a   Oron, Tal ^a   Cohen, Ohad ^b   Phillip, Moshe ^a,c   Gat Yablonski, Galia ^a,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Ashkenazi; DGGE; GCK; MODY; Mutation

Indexed keywords

GENOMIC DNA; GLUCOKINASE;

ADOLESCENT; ADULT; ARTICLE; BIOINFORMATICS; CHILD; CLINICAL ARTICLE; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC CORRELATION; HUMAN; INFANT; ISRAEL; MALE; MATURITY ONSET DIABETES MELLITUS; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AMINO ACID SUBSTITUTION; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOKINASE; HUMANS; INFANT; ISRAEL; JEWS; MALE; MODELS, MOLECULAR; MUTATION, MISSENSE; YOUNG ADULT;

EID: 84865637360     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00822.x     Document Type: Article

References (36)

1. Meur G, Simon A, Harun N et al. Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes 2010: 59: 653-661.
2. Velho G, Robert JJ. Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics. Horm Res 2002: 57(Suppl. 1): 29-33.
3. Borowiec M, Liew CW, Thompson R et al. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci USA 2009: 106: 14460-14465.
4. Jo W, Endo M, Ishizu K, Nakamura A, Tajima T. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young. Tohoku J Exp Med 2011: 223: 113-118.
5. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
6. Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy. Best Pract Res Clin Endocrinol Metab 2010: 24: 605-615.
7. Njolstad PR, Sagen JV, Bjorkhaug L et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003: 52: 2854-2860.
8. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008: 4: 200-213.
9. Osbak KK, Colclough K, Saint-Martin C et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009: 30: 1512-1526.
10. Ellard S, Beards F, Allen LI et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 2000: 43: 250-253.
11. Postic C, Shiota M, Niswender KD et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999: 274: 305-315.
12. Mahalingam B, Cuesta-Munoz A, Davis EA, Matschinsky FM, Harrison RW, Weber IT. Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia. Diabetes 1999: 48: 1698-1705.
13. Matschinsky FM. Banting Lecture 1995: a lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996: 45: 223-241.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
15. Stern E, Strihan C, Potievsky O et al. Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel. J Pediatr Endocrinol Metab 2007: 20: 909-921.
16. Cao H, Shorey S, Robinson J et al. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat 2002: 20: 478-479.
17. Galan M, Vincent O, Roncero I et al. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability. Biochem J 2006: 393: 389-396.
18. Njolstad PR, Sovik O, Cuesta-Munoz A et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001: 344: 1588-1592.
19. Estalella I, Garcia-Gimeno MA, Marina A, Castano L, Sanz P. Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. J Hum Genet 2008: 53: 460-466.
20. Atzmon G, Hao L, Pe'er I et al. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet 2010: 86: 850-859.
21. Pruhova S, Dusatkova P, Sumnik Z et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes 2010: 11: 529-535.
22. Borowiec M, Antosik K, Fendler W et al. Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population. Clin Genet. In press.
23. Oron T, Gat-Yablonski G, Lazar L, Phillip M, Gozlan Y. Stress hyperglycemia in children can be the first sign of familial diabetes. Pediatrics. In press.
24. Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993: 328: 697-702.
25. Thomson KL, Gloyn AL, Colclough K et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat 2003: 22: 417.
26. Estalella I, Rica I, Perez de Nanclares G et al. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol (Oxf) 2007: 67: 538-546.
27. Bertini C, Maioli M, Fresu P, Tonolo G, Pirastu M. A new missense mutation in the glucokinase gene in an Italian MODY family. Diabetologia 1996: 39: 1413-1414.
28. Johansen A, Ek J, Mortensen HB, Pedersen O, Hansen T. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. J Clin Endocrinol Metab 2005: 90: 4607-4614.
29. Mantovani V, Salardi S, Cerreta V et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum Mutat 2003: 22: 338.
30. Massa O, Meschi F, Cuesta-Munoz A et al. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). Diabetologia 2001: 44: 898-905.
31. Toaima D, Nake A, Wendenburg J et al. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY). Hum Mutat 2005: 25: 503-504.
32. Lorini R, Klersy C, d'Annunzio G et al. Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. Diabetes Care 2009: 32: 1864-1866.
33. Velho G, Blanche H, Vaxillaire M et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997: 40: 217-224.
34. Kousta E, Ellard S, Allen LI et al. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet Med 2001: 18: 683-684.
35. Stoffel M, Patel P, Lo YM et al. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet 1992: 2: 153-156.
36. Vits L, Beckers D, Craen M et al. Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients. Clin Genet 2006: 70: 355-359.